Diving into Dividends
Chemed, in a show of financial fortitude, declared a sturdy quarterly dividend of $0.40 per share ($1.60 annualized). This echoes the company’s previous dividend payout. Interested parties who hold shares as of February 26, 2024, can anticipate the dividend arriving in their accounts on March 15, 2024.
Historical Insights
Examining the past five years reveals that the average dividend yield has hovered around the 0.30% mark. Peaks at 0.38% and troughs at 0.24% have created a stable foundation for investors. With a standard deviation of 0.03 (n=234), the current dividend yield stands 1.14 standard deviations below this historical average.
In terms of sustainability, Chemed boasts a modest dividend payout ratio of 0.10, indicating a healthy dividend policy that aligns with the company’s earnings.
Furthermore, the company has demonstrated long-term commitment to its shareholders with a 3-Year dividend growth rate of 0.18%, showcasing consistent dividend increases over time.
Market Sentiment and Projections
Chemed has attracted attention from 1024 funds or institutions in the market, marking a 3.75% increase within the last quarter. The put/call ratio of 0.90 suggests a bullish outlook among investors. Moreover, analysts are forecasting an optimistic 8.77% upside potential with a one-year price target averaging at $649.06.
Looking at other key metrics, the projected annual revenue for Chemed is set to soar by 6.64%, with a non-GAAP EPS expected to reach 22.84, further bolstering investor confidence.
Insider Shareholder Movements
Notable insider investment management activities reflect a dynamic market environment. Kayne Anderson Rudnick Investment Management, Neuberger Berman Group, Durable Capital Partners, William Blair Investment Management, and IJH – iShares Core S&P Mid-Cap ETF have all adjusted their portfolio allocations in Chemed. This flurry of activity demonstrates the nuanced strategies employed by different institutions in response to market conditions.
Chemed Corporation Overview
Operating under the umbrella of the New York Stock Exchange, Chemed, headquartered in Cincinnati, Ohio, comprises VITAS Healthcare and Roto-Rooter as its primary subsidiaries. VITAS is recognized as a leading provider of end-of-life hospice care, while Roto-Rooter stands out as a premier plumbing and drain cleaning services provider in the nation. This diversified portfolio adds depth and resilience to Chemed’s overall market positioning.
Source: Fintel
